CYP2D6 activity and the risk of recurrence of Plasmodium vivax malaria in the Brazilian Amazon: a prospective cohort study
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CYP2D6 activity and the risk of recurrence of Plasmodium vivax malaria in the Brazilian Amazon: a prospective cohort study
Authors
Keywords
<em class=EmphasisTypeItalic >Plasmodium vivax</em>, Malaria recurrence, <em class=EmphasisTypeItalic >CYP2D6</em> gene, Polymorphisms, CYP2D6 activity score, Primaquine, Pharmacogenomics
Journal
MALARIA JOURNAL
Volume 17, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-02-01
DOI
10.1186/s12936-017-2139-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Review of Pharmacogenetics of Antimalarials and Associated Clinical Implications
- (2017) Hazem Elewa et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- TOLLIP gene variant is associated with Plasmodium vivax malaria in the Brazilian Amazon
- (2017) Larissa W. Brasil et al. MALARIA JOURNAL
- Prediction of CYP2D6 phenotype from genotype across world populations
- (2016) Andrea Gaedigk et al. GENETICS IN MEDICINE
- Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial
- (2016) Pamela L. St Jean et al. MALARIA JOURNAL
- Declining malaria transmission in rural Amazon: changing epidemiology and challenges to achieve elimination
- (2016) Sheila Vitor-Silva et al. MALARIA JOURNAL
- The effect of SNPs in CYP450 in chloroquine/primaquinePlasmodium vivaxmalaria treatment
- (2016) Vinicius A Sortica et al. PHARMACOGENOMICS
- Primaquine pharmacology in the context of CYP 2D6 pharmacogenomics: Current state of the art
- (2016) Sean R. Marcsisin et al. PHARMACOLOGY & THERAPEUTICS
- Variation in Human Cytochrome P-450 Drug-Metabolism Genes: A Gateway to the Understanding of Plasmodium vivax Relapses
- (2016) Ana Carolina Rios Silvino et al. PLoS One
- Differential CYP 2D6 Metabolism Alters Primaquine Pharmacokinetics
- (2015) Brittney M. J. Potter et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cytochrome P450 pharmacogenetics in African populations: implications for public health
- (2014) Collet Dandara et al. Expert Opinion on Drug Metabolism & Toxicology
- The clinical and public health problem of relapse despite primaquine therapy: case review of repeated relapses of Plasmodium vivax acquired in Papua New Guinea
- (2014) R Joan H Ingram et al. MALARIA JOURNAL
- Distribution of CYP2D6 Alleles and Phenotypes in the Brazilian Population
- (2014) Deise C. Friedrich et al. PLoS One
- G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications
- (2013) Lucio Luzzatto et al. BRITISH JOURNAL OF HAEMATOLOGY
- The metabolism of primaquine to its active metabolite is dependent on CYP 2D6
- (2013) Brandon S Pybus et al. MALARIA JOURNAL
- Primaquine Failure and Cytochrome P-450 2D6 in Plasmodium vivax Malaria
- (2013) Jason W. Bennett et al. NEW ENGLAND JOURNAL OF MEDICINE
- Malaria pharmacogenomics: return to the future
- (2013) JP Gil PHARMACOGENOMICS
- Glucose-6-phosphate dehydrogenase deficient variants are associated with reduced susceptibility to malaria in the Brazilian Amazon
- (2013) Marli S. Santana et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- Comparison of diagnostic methods for the detection and quantification of the four sympatric Plasmodium species in field samples from Papua New Guinea
- (2011) Anna Rosanas-Urgell et al. MALARIA JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More